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The Max Planck Society is one of
Europe’s most prestigious
science funding agencies, but the
new president, molecular
biologist Peter Gruss, faces a
tough challenge ahead with
growing competition for research
funds and the changing European
and international landscape of
research.
Based in Germany, but with
links in other European countries
and beyond, the Max Planck
Society (MPS) was established in
1948 following on from the pre-
war Kaiser Wilhelm Society.
“Germany actually had a lot of
help from the British in getting it
going”, says Gruss. “The basic
aim was to produce effective
mechanisms to complement
university research”, he says.
The MPS primarily promotes
research in its own institutes.
These carry out basic research in
areas of the natural sciences, the
social sciences and the
humanities. In particular the MPS
aims to take up new and
promising subjects in research
that universities are unable to
accommodate. Gruss, as
president, represents the MPS
and lays down the guidelines for
its scientific policy and is elected
by the senate of the society. The
MPS is not a government body.
“It is essential above all that we
retain our autonomy,” says
Gruss.
The current budget is 1.2 billion
euros. Of this, 95 per cent comes
equally from the federal
government and the individual
states. The MPS has 11,200
employees of which around 3,000
are scientists and a further 8,000
people are students or post-
doctoral fellows. However, the
budget represents just two per
cent of the total expenditure for
research and development in
Germany. And it is the battle over
this share which now looms for
the MPS.
Maintaining the ability to move
rapidly into new research areas
remains one of the key goals of
the MPS. But this has a tough
downside: the society must also
exercise its muscle to close down
areas of research either
considered to have reached their
goals, or if directors are no longer
available or if universities are
considered to be in a position to
take on the research. 
Over the past decade the MPS
has demonstrated just such
muscle. Since the early 1990s,
four institutes and one sub-
institute have been closed, and
three institutes and a number of
departments have shifted their
research focus completely. In
News focus
New champion for basic research
Peter Gruss, the new president of the Max Planck Society, believes the
society’s autonomy and flexibility offer the best prospects in the future
battle for funds. Nigel Williams reports.
Balancing act: Peter Gruss, the new president of the Max Planck Society faces the
task of shifting support from some areas of research to others to maintain the society’s
flexibility and ability to respond to changing priorities. (Photo: Max Planck Society.)
contrast, reunification has seen a
period of intense efforts to
establish a presence in the new
eastern federal states. During this
period, 18 institutes and one
research facility were set up,
mostly in these states. And last
year, the Max Planck Institute for
Vascular Biology was established
in Muenster, the first new institute
to be established in one of the
western federal states since the
1980s. The introduction of flexible
budget management in 1999 has
also allowed funds to be shifted
between previously allocated
areas.
But there are few signs now of
future expansion on this scale.
The German economy is sluggish
and the recent election has done
little to engender feelings of
change. “To my great
disappointment we received only
a 3 per cent increase in budget
which was little more than
inflation,” says Gruss. “It
compares badly with the US,
where the NIH budget is set for
major increases, and also the UK
where funding for basic science
has received a significant boost,”
he believes.
But the MPS is fighting back.
One key strategy to give the MPS
a higher international profile has
been the setting up of
International Max Planck
Research Schools. The PhD
courses are designed for
researchers both from Germany
and abroad, with at least half the
fellowships offered to candidates
from outside Germany on courses
run largely in English. The schools
are financed by the partners
involved. Planned for an initial
period of six years, they will be
evaluated after four years. An
extension for another six years
may be possible. “The
international research schools are
proving to be a big success,” says
Gruss. And numbers are already
increasing from the 19 established
by last year (shown in the figure)
and more are planned. “For
example, 20 PhD posts in the
research school for molecular
biology and neurosciences in
Goettingen attracted 400
applicants with 70 per cent of
these coming from outside
Germany,” says Gruss. Overall,
around two-thirds of applicants
are turning out to come from other
countries. “We’re getting some of
the brightest minds wishing to
come to Germany,” he says.
The search for other sources of
funds is also growing, following
the increasing European Union
support for research. In the EU’s
Fourth Framework Programme,
which ran for four years in the
mid-1990s, Max Planck institutes
won around 54 million euros. At
least 18 per cent of programme
funds granted to German
researchers went to Max Planck
institutes and 25 per cent of
funds for fellowships in Germany
were won by them too.
The EU is now pledged to
creating a European Research
Area where national barriers,
limitations on research funding
and bureaucracy are reduced.
The proposal has been backed by
the MPS. “There is an essentially
unlimited enthusiasm amongst
Max Planck scientists for
cooperation in European research
projects,” the society says.
Even more recently the notion
of creating a European research
council has been mooted by
numerous European funding
agencies. “We are keen to see
greater cooperation and
information exchange between
European funding bodies. I
believe a European research
council could set a good example
but it would be essential that
such a council is run by scientists
and not by administrators” he
says.
In the face of potential EU
enlargement with new member
states joining from Eastern
Europe, international competition
and domestic pressures, “We
have to harmonize somehow.”
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Looking out: Location of the first international research schools associated with Max
Planck Institutes and other partners. More are now being established and they have
been a “big success”, says Gruss.
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